X | ||||||||||
- Definition The total amount of termination payments possible to receive upon the occurrence of commercial sales milestones. No definition available.
|
X | ||||||||||
- Definition The total amount of termination payments possible to receive upon the occurrence of certain developmental and regulatory milestones. No definition available.
|
X | ||||||||||
- Definition The percentage of payments received by the counterparty in the event that they enter into additional subsequent license agreements. No definition available.
|
X | ||||||||||
- Definition The total amount of termination royalty payments possible to receive upon the occurrence of certain events expressed as a percentage of net sales. No definition available.
|
X | ||||||||||
- Definition The amount of money eligible to be earned in the event that the counterparty enters into additional license agreements. No definition available.
|
X | ||||||||||
- Definition Amount of total purchase consideration for acquiring license under agreement. No definition available.
|
X | ||||||||||
- Definition Represents maximum amount of reimbursement in connection with certain development milestones. No definition available.
|
X | ||||||||||
- Definition Maximum amount of reimbursement in connection with certain drug development milestones. No definition available.
|
X | ||||||||||
- Definition Represents maximum reimbursement amount under agreement in connection with product clinical Trial. No definition available.
|
X | ||||||||||
- Definition Maximum amount of reimbursement when achieving sales milestones. No definition available.
|
X | ||||||||||
- Definition The amount of cash outflow made a result of the termination of an agreement. No definition available.
|
X | ||||||||||
- Definition Amount of sales milestones required to receive maximum reimbursement. No definition available.
|
X | ||||||||||
- Definition Carrying amount of amounts due as a result of the termination of an agreement. No definition available.
|
X | ||||||||||
- Definition Carrying amount of amounts due within 90 days as a result of the termination of an agreement. No definition available.
|
X | ||||||||||
- Definition Carrying amount of amounts due within 30 days as a result of the termination of an agreement. No definition available.
|
X | ||||||||||
- Definition The cash outflow to reacquire common stock during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|